BIO VP moves to Cell Therapeutics
Executive Summary
Former Biotechnology Industry Organization VP-Communications Dan Eramian will join Cell Therapeutics as exec VP-corporate communications, the company announced Feb 28. Prior to joining BIO, Eramian worked in public affairs for the Department of Justice...
You may also be interested in...
BIO communications VP
The Biotechnology Industry Organization names Jeffrey Joseph VP-communications effective Sept. 6. The position has been vacant since Dan Eramian joined Cell Therapeutics earlier this year (1"The Pink Sheet" March 6, 2006, In Brief). Joseph was previously VP-communications & strategic relation at the Consumer Electronics Association and spent 11 years at Ogilvy Public Relations Worldwide...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.